Lv51
1330 积分 2023-04-17 加入
Comparative in vitro studies on different 6-mercaptopurine formulations for use in children
4天前
已关闭
When Impact Multiplies: Defining Trials and Insights From 2025 SGO Annual Meeting
5天前
已关闭
Best Original Research Presented at the 26th European Congress on Gynaecological Oncology: Best of ESGO 2025
5天前
已关闭
Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study
7天前
已完结
Highlights from the 26th European Congress on Gynaecological Oncology in Rome: Interviews compilation of ENYGO-IJGC Editorial Fellows
7天前
已关闭
Best Original Research Presented at the 26th European Congress on Gynaecological Oncology: Best of ESGO 2025
7天前
已关闭
B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas
10天前
已完结
Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged > 80 years with diffuse large B-cell lymphoma: a retrospective analysis
28天前
已关闭
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL
28天前
已完结
Aspirin underuse, non-compliance or cessation: Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease
1个月前
已完结
皖公网安备34019202002308
